BioCryst Pharmaceuticals Stock Price - BCRX

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 2.39 ▲ 0.01 (0.21%)
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.115 -4.6% 2.385 2.55 2.38 2.49 2.50 19:59:43
Bid Price Ask Price Spread Spread % News
2.38 3.25 0.87 26.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,579 970,862 $ 2.43 $ 2,358,842 1,517,644 2.35 - 9.97
Last Trade Time Type Quantity Stock Price Currency
17:12:41 formt 200 $ 2.39 USD

BioCryst Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 263.40M 110.44M $ -101.25M -0.98 - 106.36M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.00 3.70%

more financials information »

BioCryst Pharmaceuticals News

Loading Messages....

Latest BCRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCRX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.412.742.372.4748914k-0.025-1.04%
1 Month2.893.52.352.76811M-0.505-17.47%
3 Months3.263.62.352.86971M-0.875-26.84%
6 Months7.719.012.353.61372M-5.325-69.07%
1 Year7.139.972.354.97471M-4.745-66.55%
3 Years4.019.972.355.52931M-1.625-40.52%
5 Years11.2716.831.636.29431M-8.885-78.84%

BioCryst Pharmaceuticals Description

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.


Your Recent History
NASDAQ
BCRX
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.